# HIPRA

> Developing innovative vaccines

Business model and tags: B2B, B2C, Has physical offices, Manufacturing, Healthtech, Sales-led purchase, Pharma & life sciences, Contract manufacturer, Medical devices, Multi-site, International operations, Has production sites, Has in-house R&D, Has field sales reps, Sells through distributors, Has a works council

## About HIPRA

Biotechnological pharmaceutical company specializing in innovative vaccines and diagnostic services for animal and human health worldwide

## Key facts

- **Industry**: Pharmaceutical Manufacturing
- **Company size**: 1,001–5,000 employees
- **Headquarters**: Spain
- **Revenue**: €86.5M – €683M (Tamtam estimate)
- **Website**: [hipra.com](https://www.hipra.com/en)
- **LinkedIn**: [linkedin.com/company/hipra](https://www.linkedin.com/company/hipra)

## HIPRA at a glance

HIPRA is a B2B/B2C company in the Pharmaceutical Manufacturing industry, headquartered in Spain.

HIPRA has 1,001–5,000 employees.

HIPRA's revenue is €86.5M – €683M (Tamtam estimate).

## Frequently asked questions about HIPRA

### What is HIPRA's revenue?

Tamtam estimates HIPRA's annual revenue at €86.5M – €683M.

### How many employees does HIPRA have?

HIPRA has 1,001–5,000 employees.

### Where is HIPRA headquartered?

HIPRA is headquartered in Spain.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/hipra
